Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
15 October 1993 | Volume 119 Issue 8 | Pages 828-835
The field of cardiac pacing has expanded rapidly in recent years. Engineering improvements and microprocessor technology have resulted in a vast increase in pacemaker technology. The "high-tech" edge of cardiac pacing often discourages all but the pacemaker specialist from approaching a malfunctioning pacemaker. Electrocardiographic signs of pacemaker malfunction can be grouped into four categories: failure to output, failure to capture, undersensing, and inappropriate pacemaker rate. For each of these categories, there may be true malfunctions and pseudomalfunctions. In addition, environmental sources of electromagnetic interference, both within and outside the hospital environment, can result in pacemaker malfunction. Approaching pacemaker malfunction with these categories in mind should help minimize confusion.
REVIEW
Pacemaker Malfunction
Pacemaker malfunction, although infrequent, may have serious consequences. When malfunction occurs, symptoms may be occurring that are related to bradycardia, tachycardia, or extracardiac stimulation, but often the patient is asymptomatic. The problem is usually recognized by either direct or transtelephonic electrocardiographic monitoring, which reveals one or more of the electrocardiographic features listed in Table 1.
|
In certain circumstances, these same electrical features may be seen in a patient with normal pacemaker function. Physicians must recognize the potential for such "pseudomalfunction." This problem is minimized by careful interpretation of the paced electrocardiogram and knowledge of both the idiosyncrasies of the particular pacemaker and how it is programmed.
Several series have reviewed the incidence and types of pacemaker problems identified during long-term follow-up [1-6]. Sensing abnormalities, recognized as a lack of pacemaker artifacts or, conversely, as one or more inappropriate pacemaker artifacts, are the most common malfunction, occurring in approximately 3% of patients. Failure to capture occurs in 1% to 2% of patients; the remaining problems affect another 1%.
Although all pacemaker malfunctions can be related to problems with the pacemaker generator or the pacemaker lead (or both), it is useful to consider the differential diagnosis on the basis of the electrocardiographic signs listed in Table 1.
Failure to Output
|
|---|
|
The current lithium-powered pacemakers have a battery life that ranges from 4 to more than 12 years, depending on the current drain, which is determined by the percentage of time pacing is required, the thresholds necessary, whether single- or dual-chamber pacing is used, and whether a rate-modulating sensor or other features requiring additional current drain are included. Lithium iodine, currently the most commonly used battery, has shown predictable battery-depletion characteristics [7]. When a small voltage decrement occurs, end-of-life characteristics (such as a change in pacing rate) are triggered, signaling the need for pacemaker replacement. Once initial end-of-life changes appear, there is usually a period of months before the pacemaker battery reaches a critically low voltage and pacing fails. (Total battery depletion results in failure to output. Failure to capture can take place at a lesser degree of battery depletion.)
Oversensing is associated with the unexpected sensing of an intracardiac or extracardiac signal [8] (Figure 1). It may be intermittent, resulting in irregularly delayed pacemaker stimulation, or constant, leading to a decreased pacing rate or total inhibition of pacemaker output. Electrical signals that may cause oversensing include myopotentials, T waves, and P waves. Atrial-channel oversensing may occur when "far-field" R waves are sensed. Extrasystoles, which are nearly isoelectric in the monitored lead, may give the appearance of oversensing.
|
Oversensing of myopotentials in a single-chamber pacemaker may result in pauses, whereas oversensing of myopotentials by the atrial-sensing circuit of a dual-chamber pacemaker may result in rapid paced rhythms. Such myopotentials may be interpreted as atrial activity, and the pacemaker "tracks" the signals with ventricular pacing. Oversensing can frequently be corrected by reprogramming the sensitivity or, at times, by reprogramming the refractory period of the channel on which oversensing is occurring so that the event being inappropriately sensed occurs in the refractory period and therefore does not alter the timing cycle of the pacemaker. Oversensing of extracardiac events occurs much less commonly with bipolar sensing [9].
Although it is not a true malfunction of the pacing system, failure of output may also be the result of "cross talk"; that is, in a dual-chamber pacemaker, the pacemaker stimulus in one chamber is sensed in the other chamber [10, 11]. If the afterpotential of an atrial stimulus is sensed by the ventricular lead, ventricular output may be inhibited. For the pacemaker-dependent patient, inhibition could result in ventricular asystole. Most pacemakers have two methods of protection against such an occurrence. The first is interposition of a short period ("blanking") of refractoriness in the ventricular channel simultaneous with the atrial output stimulus. The second is adjustment of the response to sensed events on the basis of when, during the timing cycle, the event is sensed. One such response is ventricular "safety pacing," whereby any event sensed on the ventricular sensing circuit within a defined early portion of the atrioventricular delay (that is, the interval between the paced atrial event and the subsequent ventricular event) initiates the delivery of a ventricular pacing stimulus.
Another pseudomalfunction occurs when the monitor system does not display the pacemaker stimulus artifact when it is really present. This occurs more frequently with bipolar pacing, and the confusion can usually be resolved by magnet application, examination of a 12-lead electrocardiogram, or alteration of the configuration of the monitoring lead.
Failure to Capture
|
|---|
|
Failure to capture can also occur when a break in the insulation of the pacemaker catheter allows some of the current from the electrode to escape into the surrounding tissues. If the current leakage is sufficient, complete or intermittent failure of myocardial capture results.
If the pacing threshold required to depolarize the myocardium is greater than the programmed voltage amplitude and pulse duration, intermittent or total failure to capture may occur. Poor lead position is the most common cause of high thresholds, but exit block can also cause high thresholds in a few patients. Exit block, or high pacing thresholds without radiographic evidence of dislodgment, may be related to an inflammatory reaction or fibrosis at the electrode-myocardium interface [15]. In a patient with exit block, the risk for recurrent high thresholds can usually be minimized with the use of a steroid-eluting lead [16]. Failure to capture may also be induced by marked metabolic abnormalities, such as hyperkalemia, and some cardioactive drugs, such as flecainide, that alter the myocardial milieu [17].
Inappropriately low voltage-amplitude and pulse-duration settings may result in "true" failure to capture. A pacemaker artifact occurring within the myocardial refractory period Figure 3, functional loss of capture, results in a similar electrocardiographic appearance but is a pseudomalfunction.
|
Undersensing
|
|---|
|
Undersensing is most likely caused by lead dislodgment, poor lead position at the time of implantation, or an interruption in the insulation of the pacing catheter. An insulation defect may be manifested as undersensing or oversensing, or both. Undersensing may also be the result of delivery of a low-amplitude P wave or QRS complex to a normally functioning pacing system. The size of the electrical signal can be determined only from the intracardiac electrogram. The size of the signal from the intracardiac electrogram may be influenced by many factors (for example, concomitant drug therapy, body position, myocardial infarction, and the cardiomyopathic process), so that an R-or P-wave amplitude that was initially acceptable may be diminished to a level that cannot be sensed by the pulse generator. Also, the size of the atrial signal may diminish with exercise [18]. Undersensing can frequently be corrected by reprogramming the sensitivity of the pacemaker.
Sensing is suspended as the result of magnet application, which disengages the sensing amplifiers. This is the expected response and should not be considered undersensing. Extraneous electrical noise sensed by the pacemaker may switch the unit to a nonsensing mode.
In dual-chamber pacemakers, apparent undersensing may occur during the initial portion of the atrioventricular interval, or the blanking period (Figure 5). The blanking period is programmable in most dual-chamber pacemakers and may range from 12 to 125 ms. During this interval, the ventricular channel of the pacemaker is refractory to avoid sensing of the atrial stimulus and depolarization. If an intrinsic ventricular event occurs during the blanking period, it is not sensed and will give the appearance of undersensing [19, 20]. This problem can often be corrected by shortening the blanking period. If an event occurs immediately after the blanking period, it occurs during the "cross-talk sensing window." An event that occurs during this period triggers ventricular safety pacing, as previously described (Figure 5).
|
Functional undersensing may also occur when a P wave or QRS complex falls within the refractory period, that is, when a P wave occurs during the atrial refractory period or a QRS complex occurs during the ventricular refractory period (see Figure 4).
Care should be taken to avoid confusing what appear to be inappropriate pacemaker artifacts with artifacts caused by the monitoring equipment. These random occurrences, frequent in some older monitor systems, can be misleading.
Inappropriate Pacing Rates
|
|---|
Sensing abnormalities also may result in inappropriately rapid pacing rates by induction of tachydysrhythmias owing to undersensing and competitive pacing. Tracking of atrial fibrillatory or flutter waves and pacemaker re-entrant tachycardia are also inappropriate pacemaker-mediated tachycardias. (Pacemaker re-entrant tachycardia refers to a repetitive cycling that can be seen in dual-chamber pacemakers that can track atrial activity. Pacemaker re-entrant tachycardia occurs when sensing of a retrograde atrial depolarization initiates ventricular pacing, which in turn leads to retrograde conduction and repetition of the same cycle [26] (Figure 6).) Although these rhythms are pacing abnormalities that require correction, they are a function of the patient's intrinsic rhythm and the programming of the pacemaker, not true malfunctions of the pacing system.
|
Electromagnetic interference from the patient's environment may cause the generator to be reset to a rate different from that programmed. Also, many pacemakers operate at a slower rate when battery depletion is imminent (end-of-life indicator).
During "safety pacing," the atrioventricular interval is shortened; therefore, the total interval is shortened from one paced ventricular complex to the next. Repetitive safety pacing results in a slight increment in pacing, but it is not clinically significant.
Pacemaker Lead Malfunction
|
|---|
Polyurethane and silicone are used as insulating materials for most permanent pacing leads. In the early 1980s, concern arose about the long-term performance of leads with polyurethane insulation because of the early failure of several specific polyurethane-insulated leads [33-35]. Failure of specific polyurethane leads appears to be attributable to difficulties in manufacturing these specific leads and is not representative of the overall experience with polyurethane leads. Insulation defects in polyurethane leads have also been detected at stress points, particularly at the costoclavicular space in leads placed using the subclavian puncture technique [36].
Environmental Causes of Pacemaker Malfunction
|
|---|
Electrocautery
The most common piece of medical equipment to affect pacemaker function is the electrocautery, which usually causes temporary sensing problems or reprogramming but rarely causes permanent alteration of the pacemaker circuits [37]. After electrocautery is used in a patient with a permanent pacemaker, the pacemaker should be checked to confirm proper function and expected programmed settings.
Transthoracic Defibrillation
Permanent or transient electrical damage to the pulse generator can occur during transthoracic defibrillation. The effects on the pacing system may be caused by myocardial thermal damage secondary to transmission of defibrillation discharge to the heart through the leads, inappropriate reprogramming of programmable pulse generators, or damage to the pacemaker circuitry [38, 39]. The potential for such damage is minimized by incorporating a zener diode into the pacemaker that will shunt excess energy away from the pacemaker [38]. Also, to minimize the chance of pacemaker malfunction occurring with defibrillation, the defibrillation paddles should be positioned anteroposteriorly and as far from the pacemaker or lead as possible.
Magnetic Resonance Imaging
The powerful static, time-varying magnetic, and radiofrequency fields of the magnetic resonance imaging (MRI) system can affect normal pacemaker operation and function. At the least, exposure to MRI causes all pacemakers to revert to an asynchronous mode because of reed-switch closure. This effect can be avoided only in pacemakers in which the magnet response can be programmed "off." Investigations of the interaction between MRI and the pacemaker have shown that MRI does not permanently damage the reed switch or other pulse generator components. The radiofrequency artifacts do not alter the acutely programmed variables, change the normal magnet rate, or induce pacing in most pacemakers tested. Certain single- and dual-chamber pacemakers implanted in animals and exposed to MRI can pace at the radiofrequency pulse period used during radiofrequency scanning [40]. Because the radiofrequency pulse period may be set at extremely short intervals for some diagnostic procedures (available range of 20 to 2000 ms), patients with susceptible pacemakers theoretically could be paced at rates as high as 3000 beats/min.
No generalizations can be made about which patients with pacemakers can be exposed safely to MRI. In general, MRI should be avoided in a patient with an implanted pacemaker. Several approaches have been used in patients with pacemakers who need MRI scanning and for whom alternative procedures cannot provide the necessary diagnostic information. Magnetic resonance imaging may be attempted in non-pacemaker-dependent patients if the device can be programmed to an output at which there is consistent failure to capture [41]. In this case, even if the pacemaker were susceptible to rapid pacing by the radiofrequency signals, the patient should be protected from effective rapid-pacing rates. If the pacemaker can be programmed to the OOO mode, or "off," the non-pacemaker-dependent patient can probably undergo MRI safely. Alternatively, the pacemaker can be explanted for the duration of the MRI scan, but this procedure is again obviously only applicable to the non-pacemaker-dependent patient and is not without risk. Even with strict sterile technique, the patient would be exposed to some increased risk for infection. It must be remembered that if the body area to be imaged is in close proximity to the pacemaker site, the pacemaker-induced artifact on MRI may obscure the images. Because MRI is generally thought to be contraindicated in patients with permanent pacemakers, the patient must be made thoroughly aware of the risks associated with MRI.
Extracorporeal Shock-Wave Lithotripsy
Lithotriptors may cause problems in permanent pacemakers [42, 43]. The shock waves produced by the lithotripsy device are usually synchronized to the patient's ventricular depolarization or to the output stimulus of the pacemaker. Testing of pacemakers in vitro and limited experience in vivo have shown that lithotripsy does not interfere with fixed-rate VVI pacing. In patients with dual-chamber pacemakers, synchronization of the lithotriptor with the atrial output can result in inhibition of ventricular output. Therefore, the pacemaker should be reprogrammed to the VVI or VOO mode for the duration of treatment. In patients with an activity-sensing, rate-adaptive pacemaker, sensing of the shock waves can result in increased pacing rates and in damage to the piezoelectric crystal if the focal point of the lithotriptor is placed near the pacemaker.
The following guidelines should be followed when lithotripsy is done in patients with pacemakers: 1) Program the pacemaker to the VVI or VOO mode; 2) keep the focal point of the lithotriptor at least 6 inches away from the pacemaker; and 3) monitor cardiac function throughout the procedure.
Transcutaneous Electrical Nerve Stimulation
Used frequently for several neurologic and musculoskeletal problems, transcutaneous electrical nerve stimulation appears to be safe in most patients with permanent pacemakers. One study showed no pacing abnormalities in 51 patients in whom 20 different pacemakers were evaluated [44]. Individual cases have been reported documenting pacemaker inhibition by transcutaneous electrical nerve stimulation [45]. It is not known how close to the pacemaker the transcutaneous nerve stimulator can be placed, and it is best to avoid applying the stimulator to a vector or path that would be parallel to the pacing lead. Pacemaker-dependent patients should be monitored during initial transcutaneous electrical nerve stimulation to be certain that no inhibition occurs. Most of the information on this procedure in patients with permanent pacemakers has been obtained in those with relatively modern pacemakers. It is possible that some older pacemakers with less sophisticated filtering capabilities are more susceptible to interference.
In patients with VD or DDD pacemakers, transcutaneous electrical nerve stimulation may result in an increased ventricular rate. If the noise created by transcutaneous electrical nerve stimulation were sensed as atrial activity, the pacemaker could track the noise and increase the ventricular rate.
Therapeutic Radiation
Diagnostic radiography does not interfere with pacemaker function. Therapeutic radiation can have a damaging effect on pacemaker function [46, 47]. Modern pacemakers contain complementary metal oxide semiconductors for their integrated circuits, whereas older generators had discrete components. Complementary circuits are more readily damaged by lower levels of radiation than were discrete components. Specifically, when the metal oxide semiconductor is exposed to ionizing radiation, damage occurs to the silicone and silicone oxide insulators within the semiconductors. Therapeutic radiation may be sufficiently intense to cause complete failure or random damage to circuit components. Sudden output failure or runaway may occur. Because the damage to the circuit is random and the radiation dose cumulative from one therapeutic exposure to the next, no specific prediction relative to dose can be made. Some reports have noted pacemaker damage in complementary metal oxide semiconductor devices from as small a radiation dose as 10 Gy, whereas in others, damage has resulted from doses of 30 to 150 Gy.
This effect is particularly important in patients undergoing radiation for thoracic or chest wall malignant disease. If the pacemaker is within the field of radiationfor example, in patients with carcinoma of the breastmoving the pulse generator to another site may be required. If the pulse generator is not in the field of radiation, it should nevertheless be shielded to prevent damage.
Other Medical Equipment
Diathermy, electroshock therapy for the treatment of depressive disorders, and radiofrequency ablation for the treatment of tachyarrhythmias may also cause pacemaker reprogramming or inhibition. From a practical standpoint, the pacemaker should be checked after the procedure or treatment to determine that programmed parameters remain accurate.
Nonmedical Equipment and Devices
Permanent damage to implanted pacemakers by electrical equipment normally encountered at home or at work has not been reported and is unlikely. The most frequent occurrence is temporary interference with pacemaker activity while the patient is in the field of sustained electrical interference. Interpreted by the pacemaker as cardiac electrical activity, this electrical interference may inhibit pacemaker function episodically but will not damage the pacemaker.
Potentially significant restrictions exist for a small subset of patients. Each circumstance is different and involves the mutual decision of the implanting physician and the patient. In patients who work in environments with equipment capable of causing significant electromagnetic interferencefor example, heavy motors, such as internal combustion engines, or arc welding equipmenttemporary interference with pacemaker activity can result in pacemaker inhibition. In these situations, patients may be required to change occupations or at least to avoid specific equipment. If the potential for such electromagnetic interference is known before implantation, the use of bipolar leads can minimize or eliminate the problem. When the patient's livelihood involves the use of equipment that may cause electromagnetic interference, it is helpful to have the patient, accompanied by another adult, return to the workplace with an ambulatory electrocardiographic monitor. Electrocardiographic recording during brief exposure to the potentially hazardous equipment at close proximity helps to determine whether a real problem exists. If the patient has a pacemaker with the capability of storing event records, examination of the stored records after exposure to the usual work environment may help to determine whether electromagnetic interference is a concern. Occasionally, it may even be necessary to request an engineer from the pacemaker company to visit the patient's workplace and determine potential exposure to electromagnetic interference.
Patients invariably ask whether a microwave oven or radar detectors of the type used in airports interfere with pacemaker function. With present-day pulse generators, microwaves should not cause any problem. Metal detectors could theoretically cause inhibition of a single beat, but significant clinical sequelae should not result.
Phantom Programming
Several categories of phantom or false programming have been defined, including misprogramming from faulty program emission signals, dysprogramming from anomalous sources, and, most commonly, purposeful programming by a health care provider who fails to inform the patient or to record the reprogramming for future reference. Faulty program emission signals were more common when programming was accomplished by magnetic reed switching. With radiofrequency transmission of programming signals, phantom programming is uncommon.
Several sources of phantom programming occur or are detected in a hospital setting. One is exposure to cold. The pulse generator may be exposed to severe cold in the cargo hold of an aircraft or in the trunk of an automobile during delivery. After exposure to severe cold, new microprocessor-based pulse generators revert to a back-up mode that is different for each pacemaker. A special programming sequence is usually necessary to restore normal operation. Reversion to the back-up mode could also be caused by cardioversion or electrocautery, as previously discussed. If the possibility of such reversion is not anticipated in each of these instances, pacemaker malfunction may be thought to be present.
When phantom programming occurs outside the hospital, a detailed analysis of possible sources of reprogramming should be discussed with the patient to determine and avoid the cause and to ascertain that pacemaker malfunction does not exist. With the electromagnetic interference shielding provided in current pacemakers, false programming caused by exposure to this interference is infrequent. When a patient's pacemaker is found to be programmed to parameters other than those on record, the following causes should be considered: 1) reprogramming by another physician without notification of the pacemaker center; 2) use of medical equipment in the hospital for diagnostic or therapeutic procedures [for example, electrocautery and magnetic resonance imaging]; and 3) close exposure to large internal combustion engines, welding equipment, or some form of external shock.
Conclusion
|
|---|
|
|
|---|
Author and Article Information
|
|---|
|
|
|---|
References
|
|---|
|
|
|---|
1. Dreifus LS, Zinberg A, Hurzeler P, Puziak AD, Pennock R, Feldman M, et al. Transtelephonic monitoring of 25,919 implanted pacemakers. PACE. 1986; 9:371-8.
2. Griffin JC, Schuenemeyer TD, Hess KR, Glaeser D, Anderson BJ, Romans E, et al. Pacemaker follow-up: its role in the detection and correction of pacemaker system malfunction. PACE. 1986; 9:387-91.
3. Markewitz A, Hemmer W, Weinhold C. Complications in dual chamber pacing: a six-year experience. PACE. 1986; 9:1014-8.
4. Pless P, Simonsen E, Arnsbo P, Fabricius J. Superiority of multiprogrammable to nonprogrammable VVI pacing: a comparative study with special reference to management of pacing system malfunctions. PACE. 1986; 9:739-44.
5. Janosik DL, Redd RM, Buckingham TA, Blum RI, Wiens RD, Kennedy HL. Utility of ambulatory electrocardiography in detecting pacemaker dysfunction in the early postimplantation period. Am J Cardiol. 1987; 60:1030-5.
6. Heinz M, Zitzmann E, Coenen M, Alt E. Malfunctioning of DDD pacemakers despite correct functioning at routine pacemaker controls (Abstract). PACE. 1990; 13:560.
7. Hauser RG, Wimer EA, Timmis GC, Gordon S, Staller B, Klodnycky M, et al. Twelve years of clinical experience with lithium pulse generators. PACE. 1986; 9:1277-81.
8. Barold SS, Falkoff MD, Ong LS, Heinle RA. Oversensing by single-chamber pacemakers: mechanisms, diagnosis, and treatment. Cardiol Clin. 1985; 3:565-85.
9. Gabry MD, Behrens M, Andrews C, Wanliss M, Klementowicz PT, Furman S. Comparison of myopotential interference in unipolar-bipolar programmable DDD pacemakers. PACE. 1987; 10:1322-30.
10. Beaver BB, Maloney JD, Castle LW, Morant VA, Keefe JM, Ching E. Design-dependent cross-talk in a second generation DDD pacemaker. PACE. 1986; 9:65-77.
11. Sweesy MW, Batey RL, Forney RC. Crosstalk during bipolar pacing. PACE. 1988; 11:1512-6.
12. Mugica J, Ripart A. Twelve years' experience with cardiac pacing leads: clinical conclusions for 8,004 cases. Clin Prog Pacing Electrophysiol. 1984; 2:513-32.
13. Hayes DL. Pacemaker complications. In: Furman S, Hayes DL, Holmes DR Jr, eds. A Practice of Cardiac Pacing. 2d edition. Mount Kisco, New York: Futura Publishing Co.; 1989:497.
14. Hayes DL, Vlietstra RE, Trusty JM, Downing TP, Cavarocchi NC. A shorter hospital stay after cardiac pacemaker implantation. Mayo Clin Proc. 1988; 63:236-40.
15. Rosenthal JE. Exit block: cellular mechanisms. In: Zipes DP. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: W. B. Saunders Co.; 1990:409-16.
16. Hayes DL, Broadbent JC, Holmes DR Jr, Fetter JG, Neubauer SA. Steroid-tipped leads: 1-year follow-up. In: Aubert AE, Ector H, eds. Pacemaker Leads. Amsterdam: Elsevier Sciences Publishers; 1984:317-22.
17. Reiffel JA, Coromilas J, Zimmerman JM, Spotnitz HM. Drug-device interactions: clinical considerations. PACE. 1985; 8:369-73.
18. Frohlig G, Schwerdt H, Schieffer H, Bette L. Atrial signal variations and pacemaker malsensing during exercise: a study in the time and frequency domain. J Am Coll Cardiol. 1988; 11:806-13.
19. Berman ND, George CA, Duxbury GB. Apparent pacemaker malfunction due to ventricular blanking. Can J Cardiol. 1987; 3:63-5.
20. Bertuso J, Kapoor AS, Schafer J. A case of ventricular undersensing in the DDI mode: cause and correction. PACE. 1986; 9:685-9.
21. Ursell S, El-Sherif N. Electrocardiography of single-chamber pacemakers. In: Saksena S, Goldschlager N, eds. Electrical Therapy for Cardiac Arrhythmias: Pacing, Antitachycardia Devices, Catheter Ablation. Philadelphia: WB Saunders Company; 1990:205-24.
22. Campo A, Nowak R, Magilligan D, Tomlanovich M. Runaway pacemaker. Ann Emerg Med. 1983; 12:32-4.
23. Mickley H, Andersen C, Nielsen LH. Runaway pacemaker: a still existing complication and therapeutic guidelines. Clin Cardiol. 1989; 12:412-4.
24. Lee RW, Huang SK, Mechling E, Bazgan I. Runaway atrioventricular sequential pacemaker after radiation therapy. Am J Med. 1986; 81:883-6.
25. Katzenberg CA, Marcus FI, Heusinkveld RS, Mammana RB. Pacemaker failure due to radiation therapy. PACE. 1982; 5:156-9.
26. Furman S, Fisher JD. Endless loop tachycardia in an AV universal (DDD) pacemaker. PACE. 1982; 5:486-9.
27. Alt E, Volker R, Blomer H. Lead fracture in pacemaker patients. Thorac Cardiovasc Surg. 1987; 35:101-4.
28. Suzuki Y, Fujimori S, Sakai M, Ohkawa S-I, Ueda K. A case of pacemaker lead fracture associated with thoracic outlet syndrome. PACE. 1988; 11:326-30.
29. Conklin EF, Giannelli S Jr, Nealon TF Jr. Four hundred consecutive patients with permanent transvenous pacemakers. J Thorac Cardiovasc Surg. 1975; 69:1-7.
30. Clarke B, Jones S, Gray HH, Rowland E. The tricuspid valve: an unusual site of endocardial pacemaker lead fracture. PACE. 1989; 12:1077-9.
31. Gould L, Betzu R, Taddeo M, Judge JD, Lee J. Pulse generator failure due to blunt trauma. Clin Cardiol. 1988; 11:581-2.
32. Grieco JG, Scanlon PJ, Pifarre R. Pacing lead fracture after a deceleration injury. Ann Thorac Surg. 1989; 47:453-4.
33. Phillips R, Frey M, Martin RO. Long-term performance of polyurethane pacing leads: mechanisms of design-related failures. PACE. 1986; 9:1166-72.
34. Hayes DL, Holmes DR Jr, Merideth J, Osborn MJ, Vlietstra RE, Neubauer SA. Bipolar tined polyurethane ventricular lead: a four-year experience. PACE. 1985; 8:192-6.
35. Stokes KB, Church T. Ten-year experience with implanted polyurethane lead insulation. PACE. 1986; 9:1160-5.
36. Fyke FE 3d. Simultaneous insulation deterioration associated with side-by-side subclavian placement of two polyurethane leads. PACE. 1988; 11:1571-4.
37. Levine PA, Balady GJ, Lazar HL, Belott PH, Roberts AJ. Electrocautery and pacemakers: management of the paced patient subject to electrocautery. Ann Thorac Surg. 1986; 41:313-7.
38. Aylward P, Blood R, Tonkin A. Complications of defibrillation with permanent pacemaker in situ. PACE. 1979; 2:462-4.
39. Gould L, Patel S, Gomes GI, Chokshi AB. Pacemaker failure following external defibrillation. PACE. 1981; 4:575-7.
40. Hayes DL, Holmes DR Jr, Gray JE. Effect of 1.5 tesla nuclear magnetic resonance imaging scanner on implanted permanent pacemakers. J Am Coll Cardiol. 1987; 10:782-6.
41. Alagona P Jr, Toole JC, Maniscalco BS, Glover MU, Abernathy GT, Prida XE. Nuclear magnetic resonance imaging in a patient with a DDD pacemaker (Letter). PACE. 1989; 12:619.
42. Cooper D, Wilkoff B, Masterson M, Castle L, Belco K, Simmons T, et al. Effects of extracorporeal shock wave lithotripsy on cardiac pacemakers and its safety in patients with implanted cardiac pacemakers. PACE. 1988; 11:1607-16.
43. Fetter J, Patterson D, Aram G, Hayes DL. Effects of extracorporeal shock wave lithotripsy on single chamber rate response and dual chamber pacemakers. PACE. 1989; 12:1494-501.
44. Rasmussen MJ, Hayes DL, Vlietstra RE, Thorsteinsson G. Can transcutaneous electrical nerve stimulation be safely used in patients with permanent cardiac pacemakers? Mayo Clin Proc. 1988; 63: 443-5.
45. Chen D, Philip M, Philip PA, Monga TN. Cardiac pacemaker inhibition by transcutaneous electrical nerve stimulation. Arch Phys Med Rehabil. 1990; 71:27-30.
46. Brooks C, Mutter M. Pacemaker failure associated with therapeutic radiation. Am J Emerg Med. 1988; 6:591-3.
47. Adamec R, Haefliger JM, Killisch JP, Niederer J, Jaquet P. Damaging effect of therapeutic radiation on programmable pacemakers. PACE. 1982; 5:146-50.
48. Parsonnet V, Bernstein AD, Lindsay B. Pacemaker-implantation complication rates: an analysis of some contributing factors. J Am Coll Cardiol. 1989; 13:917-21.
This article has been cited by other articles:
![]() |
D. Lakkireddy, A. Khasnis, J. Antenacci, K. Ryshcon, M. K. Chung, D. Wallick, W. Kowalewski, D. Patel, H. Mlcochova, A. Kondur, et al. Do electrical stun guns (TASER-X26(R)) affect the functional integrity of implantable pacemakers and defibrillators? Europace, July 1, 2007; 9(7): 551 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nazarian, A. Roguin, M. M. Zviman, A. C. Lardo, T. L. Dickfeld, H. Calkins, R. G. Weiss, R. D. Berger, D. A. Bluemke, and H. R. Halperin Clinical Utility and Safety of a Protocol for Noncardiac and Cardiac Magnetic Resonance Imaging of Patients With Permanent Pacemakers and Implantable-Cardioverter Defibrillators at 1.5 Tesla Circulation, September 19, 2006; 114(12): 1277 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Luechinger, V. A. Zeijlemaker, E. M. Pedersen, P. Mortensen, E. Falk, F. Duru, R. Candinas, and P. Boesiger In vivo heating of pacemaker leads during magnetic resonance imaging Eur. Heart J., February 2, 2005; 26(4): 376 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Martin, J. A. Coman, F. G. Shellock, C. C. Pulling, R. Fair, and K. Jenkins Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1315 - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Duru, R Luechinger, M.B Scheidegger, T.F Luscher, P Boesiger, and R Candinas Pacing in magnetic resonance imaging environment: Clinical and technical considerations on compatibility Eur. Heart J., January 2, 2001; 22(2): 113 - 124. [PDF] |
||||
![]() |
C. D. Collard and S. C. Body Anesthetic Implications for Patients With Permanent Pacemakers Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2000; 4(3): 144 - 151. [Abstract] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||